Iparomlimab and Tuvonralimab With Chemoradiation for the Treatment of Locally Recurrent and Oligometastatic Cervical Cancer
Clinical trial NCT06942416 · RECRUITING
Trial details
- NCT number
- NCT06942416
- Sponsor
- Shandong Cancer Hospital and Institute
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-02-28
- Primary completion
- 2026-07-31
- Enrollment
- 36
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.